AIFarm, Ltd. (AIFM)

AIFarm Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Selling, General & Admin	0.49	0.09	0.61	1.71	2.64
Operating Expenses	0.49	0.09	0.61	1.71	2.64
Operating Income	-0.49	-0.09	-0.61	-1.71	-2.64
Interest Expense	-	-	-0.01	-0.02	-0.05
Interest & Investment Income	0	0	0	0	-
EBT Excluding Unusual Items	-0.49	-0.08	-0.61	-1.73	-2.69
Gain (Loss) on Sale of Assets	-	-	0.68	-	-
Asset Writedown	-	-	-	-0.04	-
Other Unusual Items	-0.06	-0.03	-	-	-
Pretax Income	-0.55	-0.11	0.06	-1.77	-2.69
Earnings From Continuing Operations	-0.55	-0.11	0.06	-1.77	-2.69
Minority Interest in Earnings	0	0	-0.01	0.15	0.68
Net Income	-0.55	-0.11	0.05	-1.62	-2.01
Net Income to Common	-0.55	-0.11	0.05	-1.62	-2.01
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change (YoY)	53.56%	64.60%	5.26%	3.56%	2.73%
EPS (Basic)	-0.97	-0.30	0.24	-7.61	-9.79
EPS (Diluted)	-0.97	-0.30	0.24	-7.61	-9.80
EBITDA	-	-0.07	-0.6	-1.68	-2.61
D&A For EBITDA	-	0.01	0.01	0.03	0.03
EBIT	-0.49	-0.09	-0.61	-1.71	-2.64
Advertising Expenses	-	-	-	0.48	0

Updated May 14, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.